These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 37945816)

  • 1. Investigation of GPR143 as a promising novel marker for the progression of skin cutaneous melanoma through bioinformatic analyses and cell experiments.
    Bai R; Yin P; Xing Z; Wu S; Zhang W; Ma X; Gan X; Liang Y; Zang Q; Lei H; Wei Y; Zhang C; Dai B; Zheng Y
    Apoptosis; 2024 Apr; 29(3-4):372-392. PubMed ID: 37945816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RARRES1 identified by comprehensive bioinformatic analysis and experimental validation as a promising biomarker in Skin Cutaneous Melanoma.
    Liu M; Bai R; Zhang G; Liu X; Wang Z; He K; Gan X; Zhou X; Yin P; Zheng Y; Wang G
    Sci Rep; 2024 Jun; 14(1):14113. PubMed ID: 38898266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low expression of endoplasmic reticulum stress-related gene SERP1 is associated with poor prognosis and immune infiltration in skin cutaneous melanoma.
    Fan Y; Liang X; Yu D
    Aging (Albany NY); 2021 Oct; 13(19):23036-23071. PubMed ID: 34613934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aspartate beta-hydroxylase domain containing 1 as a prognostic marker associated with immune infiltration in skin cutaneous melanoma.
    Sun S; Deng M; Wen J; Chen X; Xu J; Liu Y; Wan H; Wang J; Yan L; He Y; Xu Y
    BMC Cancer; 2023 Mar; 23(1):292. PubMed ID: 37004045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TREM2 as a Potential Immune-Related Biomarker of Prognosis in Patients with Skin Cutaneous Melanoma Microenvironment.
    Zhu X; Zeng Z; Chen M; Chen X; Hu D; Jiang W; Du M; Chen T; Chen T; Liao W; Zhang C; Qu Y; Pan W
    Dis Markers; 2023; 2023():8101837. PubMed ID: 36741909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression profile and prognostic values of LSM family in skin cutaneous melanoma.
    Sun X; Zhang J; Xiao C; Ge Z
    BMC Med Genomics; 2022 Nov; 15(1):238. PubMed ID: 36371223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined signature of G protein-coupled receptors and tumor microenvironment provides a prognostic and therapeutic biomarker for skin cutaneous melanoma.
    Song B; Wang K; Peng Y; Zhu Y; Cui Z; Chen L; Yu Z; Song B
    J Cancer Res Clin Oncol; 2023 Dec; 149(20):18135-18160. PubMed ID: 38006451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive analysis of the prognosis and biological significance for IFIT family in skin cutaneous melanoma.
    Jiang Y; Zhang C; Zhang J; Han D; Shi X
    Int Immunopharmacol; 2021 Dec; 101(Pt A):108344. PubMed ID: 34763233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Potential Diagnostic and Prognostic Biomarker TMEM176B and Its Relationship With Immune Infiltration in Skin Cutaneous Melanoma.
    Jiang L; Yang Y; Liu F; Ma M; Gao J; Sun L; Chen Y; Shen Z; Wu D
    Front Cell Dev Biol; 2022; 10():859958. PubMed ID: 35399535
    [No Abstract]   [Full Text] [Related]  

  • 10. System analysis based on the pyroptosis-related genes identifes GSDMD as a novel therapy target for skin cutaneous melanoma.
    Zhao S; Zhu Y; Liu H; He X; Xie J
    J Transl Med; 2023 Nov; 21(1):801. PubMed ID: 37950289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pan-cancer analysis of ubiquitin-specific protease 7 and its expression changes in the carcinogenesis of scar ulcer].
    Zhang SY; Ruan JJ; Jin DM; Chen N; Xie WG; Ruan QF
    Zhonghua Shao Shang Yu Chuang Mian Xiu Fu Za Zhi; 2023 Jun; 39(6):518-526. PubMed ID: 37805766
    [No Abstract]   [Full Text] [Related]  

  • 12. Analysis on tumor immune microenvironment and construction of a prognosis model for immune-related skin cutaneous melanoma.
    Wu M; Wang Z; Zhang J
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 May; 48(5):671-681. PubMed ID: 37539569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Overexpression of SLC25A13 Predicts Poor Prognosis and Is Correlated with Immune Cell Infiltration in Patients with Skin Cutaneous Melanoma.
    Lv Y; Yuan CH; Han LY; Huang GR; Ju LC; Chen LH; Han HY; Zhang C; Zeng LH
    Dis Markers; 2022; 2022():4091978. PubMed ID: 35607442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lower Expression of GBP2 Associated With Less Immune Cell Infiltration and Poor Prognosis in Skin Cutaneous Melanoma (SKCM).
    Zhang S; Chen K; Zhao Z; Zhang X; Xu L; Liu T; Yu S
    J Immunother; 2022 Jul-Aug 01; 45(6):274-283. PubMed ID: 35543550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PMEL as a Prognostic Biomarker and Negatively Associated With Immune Infiltration in Skin Cutaneous Melanoma (SKCM).
    Zhang S; Chen K; Liu H; Jing C; Zhang X; Qu C; Yu S
    J Immunother; 2021 Jul-Aug 01; 44(6):214-223. PubMed ID: 34028390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of NLRP3 in the prognosis and immune infiltrates of skin cutaneous melanoma (SKCM).
    Wu S; Zang Q; Dai B
    Transl Cancer Res; 2021 Apr; 10(4):1692-1702. PubMed ID: 35116494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FANCI serve as a prognostic biomarker correlated with immune infiltrates in skin cutaneous melanoma.
    Cai Z; Duan Y; Li W; Liu Z; Gong Z; Hong S; He X; Xuanyuan X; Chen Y; Bi X; Wang W
    Front Immunol; 2023; 14():1295831. PubMed ID: 38077326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HOPX is a tumor-suppressive biomarker that corresponds to T cell infiltration in skin cutaneous melanoma.
    He S; Ding Y; Ji Z; Yuan B; Chen J; Ren W
    Cancer Cell Int; 2023 Jun; 23(1):122. PubMed ID: 37344870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FLG Is a Potential Biomarker of Prognosis and Immunotherapy in Skin Cutaneous Melanoma.
    Wu S; Liang Y; Zang Q; Xing Z; Yin P; Sun R; Dai B
    Appl Bionics Biomech; 2022; 2022():5160748. PubMed ID: 35607429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multi-omics analysis of tumor mutation burden combined with immune infiltrates in melanoma.
    Jiang F; Wu C; Wang M; Wei K; Zhou G; Wang J
    Clin Chim Acta; 2020 Dec; 511():306-318. PubMed ID: 33164879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.